Amphastar Pharmaceuticals's total assets for Q1 2025 were $1.63B, an increase of 3.09% from the previous quarter. AMPH total liabilities were $874.99M for the fiscal quarter, a 3.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.